Lucid Diligence Brief: Enodia Therapeutics Kezar Sec61 deal
March 13, 2026biotech,Oncology,immunology,Lucid Diligence Brief,diligence,translational medicine,protein degradation,Sec61,Enodia Therapeutics,Kezar Life Sciencespreclinical assets
Lucid Diligence Brief: Enodia Therapeutics Kezar Sec61 deal Professional…
Rare Disease Video Recap—March 12, 2026
March 12, 2026Pegunigalsidase alfa,Chiesi Global Rare Diseases,sanofi,homozygous familial hypercholesterolemia,Fabry Disease,JUXTAPID,BioPharma and Tech News,Sangamo Therapeutics,Behcet’s disease,Protalix BioTherapeutics,Rilzabrutinib,Eledon Pharmaceuticals,Selumetinib,Tegoprubart,Alexion,Liver Transplantation,AstraZeneca Rare Disease,Meiji Seika Pharma,KOSELUGO,Immunoglobulin G4-Related Disease,Neurofibromatosis Type 1,Morcamilast,Soligenix,Palmoplantar Pustulosis,Rare Disease News,Lomitapide,ElfabrioIsaralgagene Civaparvovec,Plexiform neurofibromas
This biweekly Rare diseases video recap highlights regulatory decisions, orphan…
Cardiovascular Video Recap—March 12, 2026
March 12, 2026MIRACLE2,Out Of Hospital Cardiac Arrest,BioPharma and Tech News,Rice University,HEART FAILURE,Baylor College Of Medicine,diabetes,CardioMEMS HERO,hypertension,Pulmonary Artery Pressure Monitoring,Relief Cardiovascular,NIHR,Cardiovascular News,British Heart Foundation,Abbott,AVIM Therapy,Orchestra BioMed,Hypertensive Heart Disease,Heart failure with preserved ejection fraction,Singapore Ministry Of Health,LDL cholesterol,Hyperlipidaemia,Relief System,ACC/AHA,Synapxe,Acute Pulmonary EmbolismACE-AI,King’s College London
This biweekly Cardiovascular Video Recap covers regulatory clearances, early…
Vaccines Today—March 13, 2026
March 12, 2026varicella vaccine,Nipah virus infection,dengue,Nipah virus vaccine,breast cancer,EuBiologics,BioPharma and Tech News,Serum Institute of India,Chikungunya,ETVAX,breast cancer vaccine,Scandinavian Biopharma,Chikungunya Vaccine,Enterotoxigenic Escherichia Coli,Dengue Vaccine,Pediatric Diarrhea,Bavarian Nordic,Sinergium Biotech,Influenza Vaccine,MAV/06,GC Biopharma,Chickenpox,Anixa Biosciences,Butantan Institute,Vaccine news,Butantan-DV,CSL SeqirusCHIKV VLP,influenza
This week’s Vaccines Research update highlights clinical progress, durable…
Cardiovascular Today—March 12, 2026
March 12, 2026Synapxe,ACE-AI,BioPharma and Tech News,Cardiovascular Disease Screening,HEART FAILURE,King’s College London,Relief Cardiovascular,MIRACLE2,Cardiovascular News,Out Of Hospital Cardiac Arrest,Mitria Medical,Rice University,Subvalvular Spacer,Baylor College Of Medicine,Functional Mitral Regurgitation,CVRx,Barostim,Heart Failure With Reduced Ejection Fraction,CathWorks,FFRangioFractional Flow Reserve,Relief System
This week’s Cardiovascular update highlights new clinical guidance, device…
Cell and Gene Therapy Today—March 12, 2026
March 12, 2026ST-920,Atamyo Therapeutics,Huntington's disease,ATA-200,Fabry Disease,Limb-Girdle Muscular Dystrophy Type R5,BioPharma and Tech News,Lonza,Capricor Therapeutics,ZYNTEGLO,deramiocel,Transfusion-Dependent Beta-Thalassemia,AMT-130,Astellas Gene Therapies,uniQure,ASP2957,Cell and Gene Therapy News,X-Linked Myotubular Myopathy,GenSight Biologics,C-Further,Leber hereditary optic neuropathy,Pediatric Cancers,MiNK Therapeutics,Duchenne Muscular Dystrophy Cardiomyopathy,Genetix Biotherapeutics,Sanaregen Vision Therapeutics,LUMEVOQ,SVT-001Sangamo Therapeutics,Familial Drusen
This week’s Gene and Cell Therapy update highlights regulatory progress, early…
Rare Diseases Today—March 12, 2026
March 12, 2026Therna Biosciences,Charles River,Fabry Disease,Lamb-Shaffer Syndrome,BioPharma and Tech News,Sangamo Therapeutics,Alexion,ST-920,AstraZeneca Rare Disease,Ultra-Rare Lung Fibrosis,KOSELUGO,Protalix BioTherapeutics,Neurofibromatosis Type 1,Andelyn Biosciences,Lundbeck,Palvella Therapeutics,GeneDx,Eledon Pharmaceuticals,Rare Disease News,Tegoprubart,Elfabrio,Liver Transplantation,Zevra Therapeutics,Amlenetug,Niemann–Pick disease type C,Multiple System Atrophymicrocystic lymphatic malformations,Chiesi Global Rare Diseases
This week’s Rare Diseases update highlights regulatory approvals, gene therapy…
Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million
March 12, 2026Oncology,market access,diagnostics,Lucid Diligence Brief,diligence,companion diagnostics,pathology,Agilent,Biocare Medical,immunohistochemistry,clinical diagnosticshealthcare M&A
Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million…
AI in Healthcare and Digital Health Video Recap—March 11, 2026
March 11, 2026emergency triage,suicide-risk alerts,remote patient monitoring,Indo-French Centre for AI in Health,astrazeneca,CNS drug discovery,merck,genome foundation model,Insilico Medicine,AI-native clinical development,schizophrenia,BioPharma and Tech News,Bipolar Disorder,Mayo Clinic,OpenAI,AI in Healthcare and Digital Health,Major depressive disorder,ChatGPT HealthEvo 2,consumer triage AI
This biweekly AI in Healthcare and Digital Health video recap highlights safety…
Neuroscience Today—March 11, 2026
March 11, 2026Focal Onset Seizures,Bipolar Mania,Alzheimer's Disease,Therna Biosciences,Duchenne Muscular Dystrophy,Charles River,BioPharma and Tech News,Lamb-Shaffer Syndrome,TG Therapeutics,Z-Rostudirsen,BRIUMVI,Z-Basivarsen,Dyne Therapeutics,SPR,Neuroscience News,SPRINT Peripheral Nerve Stimulation,Relapsing multiple sclerosis,Chronic Shoulder Pain,myotonic dystrophy type 1,cognito therapeutics,spectris,Rapport TherapeuticsTenacia Biotechnology,RAP-219
This week’s Neuroscience update highlights partnership activity, clinical trial…
Immunology Video Recap—March 11, 2026
March 11, 2026Immunology News,IMAAVYDupixent,abbvie,Systemic lupus erythematosus,pfizer,Allergic fungal rhinosinusitis,roche,risankizumab,sanofi,SKYRIZI,Atopic Dermatitis,Nipocalimab,BioPharma and Tech News,warm autoimmune hemolytic anemia,psoriatic arthritis,obinutuzumab,Crohns Disease,Gazyva,Dupilumab,Tilrekimig,Regeneron,NUMELVI,Johnson & Johnson,Atinvicitinib,Deucravacitinib,Merck Animal Health,Sotyktu,Allergic Dermatitis,Bristol Myers Squibb,Canine Pruritus
This biweekly Immunology video recap highlights regulatory approvals,…
Immunology Today—March 11, 2026
March 11, 2026Deucravacitinib,Nemluvio,Sotyktu,Nemolizumab,Amgen,Bristol Myers Squibb,gsk,Immunology News,pfizer,Systemic lupus erythematosus,roche,primary biliary cholangitis,sanofi,Teva Pharmaceuticals,Atopic Dermatitis,Prurigo nodularis,BioPharma and Tech News,Nipocalimab,psoriatic arthritis,obinutuzumab,Galderma,Duvakitug,Ulcerative Colitis,Gazyva,Crohns Disease,Gazyvaro,Johnson & Johnson,Tilrekimig,Rocatinlimab,AlfasigmaKyowa Kirin,Linerixibat
This week’s Immunology update highlights regulatory progress, positive…







